NL
DE
26 July 2019
Nicoline Hoogerbrugge is specialised in the recognition, diagnosis and treatment of hereditary cancer and also focusses on the prevention of hereditary cancer in family members. In recent years her aim has been to increase the knowledge of genetic factors of cancer in young people or in people who get cancer several times. Since 2017 she has been leading a European Reference Network into genetic tumour risk syndromes (ERN GENTURIS). This is an intensive European collaborative project recognised by the EU with researchers and medical specialists in the area of hereditary cancer.
Michiel Vermeulen is research director at the RIMLS-FNWI institute. In his research he uses integrative system-biological applications such as next-generation sequencing and mass spectrometry to study gene expression regulation in sickness and health. In 2012 he received an ERC Starting Grant, followed by an ERC Consolidator Grant in 2017 for research into stem cells present in the intestine. For this research he uses ‘mini-intestines’ cultured in vitro, also known as organoids. Michiel Vermeulen’s research group is also part of Oncode Institute, a prestigious virtual national institute that carries out fundamental and applied cancer research.
The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members. Membership is only by invitation after peer group nomination, scrutiny and confirmation as to the scholarship and eminence of the individual in their chosen field. Election is confirmed by the Council of the Academia. Members are drawn from across the whole European continent, not only Western Europe. Members also include European scholars who are resident in other regions of the world. Current membership stands at around 4000. Amongst them are seventy-two Nobel Laureates, several of whom were elected to the Academia before they received the prize.
In addition to Nicoline Hoogerbrugge and Michiel Vermeulen, Bart Jan Kullberg, Bas Bloem, Joost Hoenderop, Bart Kiemeney, Barbara Franke, Guillen Fernandez, Mihai Netea, John Jansen, Jan Smeitink, Carl Figdor, Jos van der Meer, Han Brunner, René Bindels, Han van Krieken, Maroeska Rovers, Nico Verdonschot and Joost Drenth are also members of the Academia Europaea.
Nicoline Hoogerbrugge is specialised in the recognition, diagnosis and treatment of hereditary cancer and also focusses on the prevention of hereditary cancer in family members. In recent years her aim has been to increase the knowledge of genetic factors of cancer in young people or in people who get cancer several times. Since 2017 she has been leading a European Reference Network into genetic tumour risk syndromes (ERN GENTURIS). This is an intensive European collaborative project recognised by the EU with researchers and medical specialists in the area of hereditary cancer.
Michiel Vermeulen is research director at the RIMLS-FNWI institute. In his research he uses integrative system-biological applications such as next-generation sequencing and mass spectrometry to study gene expression regulation in sickness and health. In 2012 he received an ERC Starting Grant, followed by an ERC Consolidator Grant in 2017 for research into stem cells present in the intestine. For this research he uses ‘mini-intestines’ cultured in vitro, also known as organoids. Michiel Vermeulen’s research group is also part of Oncode Institute, a prestigious virtual national institute that carries out fundamental and applied cancer research.
The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members. Membership is only by invitation after peer group nomination, scrutiny and confirmation as to the scholarship and eminence of the individual in their chosen field. Election is confirmed by the Council of the Academia. Members are drawn from across the whole European continent, not only Western Europe. Members also include European scholars who are resident in other regions of the world. Current membership stands at around 4000. Amongst them are seventy-two Nobel Laureates, several of whom were elected to the Academia before they received the prize.
In addition to Nicoline Hoogerbrugge and Michiel Vermeulen, Bart Jan Kullberg, Bas Bloem, Joost Hoenderop, Bart Kiemeney, Barbara Franke, Guillen Fernandez, Mihai Netea, John Jansen, Jan Smeitink, Carl Figdor, Jos van der Meer, Han Brunner, René Bindels, Han van Krieken, Maroeska Rovers, Nico Verdonschot and Joost Drenth are also members of the Academia Europaea.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
RIMLS awards call for nominations
19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more
RIMLS online award ceremony proudly presenting the winners
13 January 2021In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.
read more
Granted research projects 2020 by Hanarth Fonds
8 December 2020 The Hanarth Fonds finances research projects of Iris Nagtegaal and Johannes Textor that use artificial intelligence or machine learning to improve the diagnosis, treatment and outcome of patients with cancer. read more
The Metastatic Microbiome rewarded with a Dutch Cancer Society Grant
24 September 2020 Annemarie Boleij, Iris Nagtegaal & Daniele Tauriello received the Dutch Cancer Society (KWF) Grant to explore the role of bacteria on colorectal cancer metastasis. read more
ZonMw funding for teams of Michiel Vermeulen and Jolanda de Vries
4 February 2020The awarded research projects of RIMLS researchers Michiel Vermeulen, Jolanda de Vries, Gerty Schreibelt and Martijn Verdoes and colleagues will initiate new research lines and collaborations between various research groups.
read more
